Abou Chakra M, McElree IM, Mott SL, O'Donnell MA, et al. Impact of American Urological Association risk category on outcomes of intravesical BCG vs gemcitabine/docetaxel in high-grade Ta non-muscle-invasive bladder cancer. BJU Int 2026 Jan 19. doi: 10.1111/bju.70149.
PMID: 41552893